We are live on
!
Find out more
IP
Isthmus Partners Portfolio holdings
AUM
$1.03B
1-Year Est. Return
22.86%
This Fund
S&P 500
This Quarter
Est. Return
+4.64%
1 Year Est. Return
+22.86%
3 Year Est. Return
+61.07%
5 Year Est. Return
+76.25%
10 Year Est. Return
+352.5%
AUM
$304M
AUM Growth
+$4.41M
(+1.5%)
Cap. Flow
-$6.35M
Cap. Flow
% of AUM
-2.09%
Top 10 Holdings %
Top 10 Hldgs %
23.43%
Holding
253
New
2
Increased
22
Reduced
99
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IQVIA
IQV
|
+$5.64M |
| 2 |
BSTC
BioSpecifics Technologies Corp.
BSTC
|
+$637K |
| 3 |
ARLZ
Aralez Pharmaceuticals Inc.
ARLZ
|
+$234K |
| 4 |
IRIDEX
IRIX
|
+$175K |
| 5 |
SLB Ltd
SLB
|
+$149K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VAL
Valspar
VAL
|
+$7.01M |
| 2 |
CLR
CONTINENTAL RESOURCES INC.
CLR
|
+$663K |
| 3 |
MASI
Masimo
MASI
|
+$615K |
| 4 |
TFM
THE FRESH MARKET, INC COM STK
TFM
|
+$561K |
| 5 |
Charles River Laboratories
CRL
|
+$290K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.45% |
| 2 | Industrials | 18.46% |
| 3 | Technology | 16.64% |
| 4 | Financials | 11.78% |
| 5 | Consumer Staples | 6.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Johnson & Johnson
JNJ
$635B
| $7.5M | 2.47% |
61,830
-1,405
| -2% | -$160K |
|
2
Kimberly-Clark
KMB
$36.4B
| $7.34M | 2.41% |
53,386
-1,390
| -3% | -$182K |
|
3
ExxonMobil
XOM
$651B
| $7.26M | 2.39% |
77,462
+23
| +0% | +$2.03K |
|
4
Medtronic
MDT
$107B
| $7.16M | 2.36% |
82,525
-2,419
| -3% | -$196K |
|
|
5
SLB Ltd
SLB
$77.8B
| $7.11M | 2.34% |
89,929
+1,938
| +2% | +$149K |
|
6
Microsoft
MSFT
$2.84T
| $7.11M | 2.34% |
138,854
-2,292
| -2% | -$119K |
|
7
Sysco
SYY
$39.7B
| $7.06M | 2.32% |
139,128
-4,166
| -3% | -$202K |
|
8
Baxter International
BAX
$11.6B
| $7.03M | 2.31% |
155,343
-2,520
| -2% | -$111K |
|
9
Becton Dickinson
BDX
$43.1B
| $6.96M | 2.29% |
42,069
-1,629
| -4% | -$260K |
|
10
Automatic Data Processing
ADP
$100B
| $6.7M | 2.2% |
72,956
-1,720
| -2% | -$152K |
|
11
Nordson
NDSN
$16.5B
| $6.67M | 2.19% |
79,784
-1,867
| -2% | -$150K |
|
|
CLR
12
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $6.48M | 2.13% |
143,175
-16,878
| -11% | -$663K |
|
13
Keysight
KEYS
$54.5B
| $6.38M | 2.1% |
219,311
+303
| +0.1% | +$8.57K |
|
14
Intel
INTC
$466B
| $6.24M | 2.05% |
190,333
-2,547
| -1% | -$79.8K |
|
|
ESRX
15
DELISTED
Express Scripts Holding Company
ESRX
| $6.04M | 1.99% |
79,642
-392
| -0.5% | -$28.8K |
|
16
Commerce Bancshares
CBSH
$8.5B
| $5.99M | 1.97% |
203,558
-6,488
| -3% | -$187K |
|
17
Accenture
ACN
$89.9B
| $5.93M | 1.95% |
52,376
-921
| -2% | -$107K |
|
18
Ball Corp
BALL
$17B
| $5.91M | 1.95% |
163,570
-2,248
| -1% | -$81.4K |
|
19
Parker-Hannifin
PH
$125B
| $5.91M | 1.94% |
54,705
-666
| -1% | -$74.7K |
|
20
Quest Diagnostics
DGX
$25.1B
| $5.89M | 1.94% |
72,318
-938
| -1% | -$71.4K |
|
21
Emerson Electric
EMR
$82.9B
| $5.88M | 1.94% |
112,764
-833
| -0.7% | -$44.2K |
|
22
Cisco
CSCO
$450B
| $5.83M | 1.92% |
203,148
-209
| -0.1% | -$5.87K |
|
23
Western Union
WU
$2.57B
| $5.62M | 1.85% |
293,176
-3,003
| -1% | -$58.3K |
|
24
Boeing
BA
$165B
| $5.6M | 1.84% |
43,098
-205
| -0.5% | -$26.7K |
|
|
BNY
25
Bank of New York Mellon
BNY
$108B
| $5.59M | 1.84% |
143,957
-1,534
| -1% | -$61K |
|
Similar funds
CM
CFFNO
RIM
TBA
JSC
MGWM
MSIIA
NFG
Isthmus Partners's Q2 2016 Portfolio in Review
As of Q2 2016, Isthmus Partners held 253 positions worth $304M, up 1.5% from $300M the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q2 2016: portfolio turnover was 2.8%. Isthmus Partners opened 2 new positions and exited 5, leaving the 253-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 20% a quarter earlier, followed by Industrials and Technology.
- Isthmus Partners's largest Q2 2016 buy was IQVIA: 84,231 shares worth $5.5M.
- Isthmus Partners added most to Aralez Pharmaceuticals Inc. in Q2 2016, an estimated $234K increase.
- Isthmus Partners's biggest Q2 2016 reduction was Valspar, cutting an estimated $7.01M.
- Isthmus Partners fully exited THE FRESH MARKET, INC COM STK in Q2 2016, selling an estimated $561K.
- Isthmus Partners's ten largest holdings make up 23% of its $304M portfolio in Q2 2016.
- Isthmus Partners opened 2 new positions and closed 5 in Q2 2016.
- Isthmus Partners's portfolio value rose 1.5% quarter-over-quarter to $304M.
Based on Isthmus Partners's 13F filing for Q2 2016, filed 8 Aug 2016.